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Depolarization of nerve terminals stimulates rapid dephos-
phorylation of two isoforms of dynamin I (dynI), mediated by
the calcium-dependent phosphatase calcineurin (CaN). De-
phosphorylation at the major phosphorylation sites Ser-774/
778 promotes a dynI-syndapin I interaction for a specific mode
of synaptic vesicle endocytosis called activity-dependent bulk
endocytosis (ADBE). DynI has two main splice variants at its
extreme C terminus, long or short (dynIxa and dynIxb) varying
only by 20 (xa) or 7 (xb) residues. Recombinant GST fusion pro-
teins of dynIxa and dynIxb proline-rich domains (PRDs) were
used to pull down interacting proteins from rat brain nerve ter-
minals. Both bound equally to syndapin, but dynIxb PRD exclu-
sively bound to the catalytic subunit of CaNA, which recruited
CaNB. Binding of CaNwas increased in the presence of calcium
and was accompanied by further recruitment of calmodulin.
Point mutations showed that the entire C terminus of dynIxb is
a CaN docking site related to a conserved CaN docking motif
(PXIXI(T/S)). This sequence is unique todynIxb among all other
dynamin variants or genes. Peptide mimetics of the dynIxb tail
blocked CaN binding in vitro and selectively inhibited depolar-
ization-evoked dynI dephosphorylation in nerve terminals but
not of other dephosphins. Therefore, docking to dynIxb is
required for the regulation of both dynI splice variants, yet it
does not regulate the phosphorylation cycle of other dephos-
phins. The peptide blocked ADBE, but not clathrin-mediated
endocytosis of synaptic vesicles. Our results indicate that Ca2
influx regulates assembly of a fully active CaN-calmodulin com-
plex selectively on the tail of dynIxb and that the complex is
recruited to sites of ADBE in nerve terminals.
The dynamins are a superfamily of up to seven cellular
GTPase enzymes,which each play a role inmembrane fission or
fusion (1). There are three “classical dynamins,” dynI,2 -II, and
-III, which mediate the internal fission of vesicles from cell
membranes. The neuronal isoform of dynamin, dynI, is essen-
tial for all forms of synaptic vesicle (SV) endocytosis in central
nerve terminals (2, 3). At least three different SV endocytosis
modes are proposed to exist in nerve terminals. The kiss-and
runmode has no defining biochemical or morphological mark-
ers, and thus its existence is still a matter of controversy (4).
Clathrin-mediated endocytosis (CME) retrieves single SVs
from the plasma membrane and is the dominant endocytosis
mode during mild stimulation (5). In contrast, activity-depen-
dent bulk endocytosis (ADBE) invaginates large areas of plasma
membrane to form bulk endosomes (BEs) from which SVs can
later bud and rejoin the recycling pool (6, 7). ADBE is only
triggered during high intensity stimulation and is the dominant
SV endocytosis mode under these conditions (8).
CME and ADBE appear to utilize similar or the same endo-
cytic proteins (9, 10), with some exceptions (3, 11). In agree-
ment, dynI GTPase activity is essential for both modes (3).
However, ADBE is additionally reliant on the dephosphory-
lation and rephosphorylation of dynI (3, 12, 13). DynI is the
founding member of a group of endocytic proteins called the
dephosphins that are dephosphorylated by theCa2- and calm-
odulin-dependent protein phosphatase calcineurin (CaN, or
protein phosphatase 2B) upon nerve terminal depolarization
(14–17). CaN is the only protein phosphatase directly regulated
by Ca2 and calmodulin (18–20). It is a heterodimer of a
60-kDa catalytic subunit, CaNA, and a 19-kDa regulatory sub-
unit, CaNB. DynI interacts directly with CaN in a strictly Ca2-
dependent manner via its PRD (21, 22); however, no functional
role has been identified for this interaction. In contrast, the
activity-dependent dephosphorylation of dynI by CaN is essen-
tial for the triggering of ADBE. DynI dephosphorylation per-
mits its association with syndapin I, a protein that is essential
for ADBE but not CME (3, 23). Thus, CaN activity is required to
trigger ADBE in central neurons to increase endocytic capacity
under periods of unusually intense activity.
DynI is a modular protein, containing an N-terminal
GTPase, middle, GTPase effector, pleckstrin homology do-
main, and proline-rich domain (PRD). The dynI PRD is located
at theC terminus,which is themain site of phosphorylation and
an interaction platform for a variety of Src homology 3 (SH3)
domains from other proteins. Rat dynI has three sites for alter-
native splicing that produce up to eight mRNAs (UniProtKB
accession number P21575) (24); however, there is limited
understanding of the functional roles of these splice variants in
neurons (25–27). The dynI third splice site produces three
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Tables 1–3 and Figs. S1–S4.
1 To whom correspondence should be addressed. Tel.: 61-2-9687-2800; Fax:
61-2-9687-2120; E-mail: probinson@cmri.org.au.
2 The abbreviations used are: dyn, dynamin; SV, synaptic vesicle; CaN, cal-
cineurin; CaM, calmodulin; PRD, proline-rich domain; SH3, Src homology 3;
ADBE, activity-dependentbulk endocytosis; CME, clathrin-mediatedendo-
cytosis; TES, N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid;
BE, bulk endosome; NFAT, nuclear factor of activated T cells.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 286, NO. 35, pp. 30295–30303, September 2, 2011
© 2011 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
SEPTEMBER 2, 2011•VOLUME 286•NUMBER 35 JOURNAL OF BIOLOGICAL CHEMISTRY 30295
alternative C-terminal tails beginning at residue 845, dynIxa
(long), dynIxb (short), or dynIxd (intermediate). The twomajor
spliced tails (xa and xb) have an approximate ratio of 5:4 (xa/ (xb
 xd)) in nerve terminals, with dynIxd expression being10%
of the others (27). DynIxa has a unique 20-residue tail after
Pro-844, 844PSRSGQASPSRPESPRPPFDL864, which includes
several potential additional binding sites for SH3 domain-con-
taining proteins. In contrast, the unique 7-residue tail of
dynIxb, 844PRITISDP851, does not. Both dynIxa and dynIxb are
phosphorylated and dephosphorylated upon electrical or
chemical depolarization to approximately equal extents using
metabolic 32Pi labeling, suggesting that they are coordinately
regulated (28). However, quantitative mass spectrometry
(which also detects unlabeled phosphorylation sites) revealed
major differences in the distribution of phosphate between
these sites in the dynIxa and dynIxb (27). Thus, the presence of
alternative binding platforms and differential phosphorylation
of key sites supports the hypothesis that these dynI splice vari-
ants may have unique functional roles in nerve terminals.
To date, the only reported differences between any of the
endogenously expressed dynI isoforms is a differential phos-
phoregulation of dynIxa in synaptosomes (27, 29). DynI is phos-
phorylated at seven sites in nerve terminals, with the majority
(69%) of metabolic labeling with 32Pi occurring on Ser-774 and
Ser-778 in a region of the PRD called the phospho-box (13, 29).
However, two additional phosphosites in nerve terminals are
unique for dynIxa, Ser-851 and Ser-857 (29). Among these two
sites, Ser-857 is phosphorylated by Dyrk 1A/minibrain kinase
in vitro, and this appears to affect amphiphysin I binding to this
isoform (30, 31).
In an attempt to uncover different roles for different dynI
splice variants in nerve terminals, we searched for protein part-
ners whose interaction may be specific for either dynIxa or
dynIxb. We report here that CaN uniquely associates with the
short (xb) tail and not with the long (xa) tail of dynI. We char-
acterized the dynIxb-CaN interaction,mapped the binding site,
and found that the interaction was associated with a specific
endocytic mode, ADBE. Our results support the model
whereby dynI dephosphorylation by CaN is the primary trigger
for ADBE, leading to the formation of a dynI-syndapin I com-
plex as the next step in the process.
EXPERIMENTAL PROCEDURES
Materials—Leupeptin was from Merck. Tissue culture plas-
tics were from Falcon (Franklin Lakes, NJ). Tetramethylrhoda-
mine-dextran, penicillin/streptomycin, phosphate-buffered
saline, minimal essential medium, and fetal calf serum were
from Invitrogen. All other materials were from Sigma unless
otherwise stated. Antibodies to PP2B-A (CaN-A), PP2B-B
(CaN-B), amphiphysin I, and syndapin I were from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA); antibodies to dynI
(hudy1) or calmodulin were from Millipore; and secondary
antibodies were all from Dako. Three penetratin-based pep-
tides, RRMKWKK-GVPRITISDP (short peptide), RRMK-
WKK-GVARATASDP (mutant short peptide), and RRMK-
WKK-GVPSRSGQASPSRPESPRPPFDL (long peptide), were
synthesized by Auspep (Parkville, Australia). The pBJ5mCaNB
(mouse, plasmid 17872), pBJ5-CaNA (mouse, plasmid 11785),
and pGEX-CaNA(2–347) (human, plasmid 13251) plasmids
were from Addgene Inc.
Plasmid Construction and Protein Expression—GST-tagged
dynIxa PRD plasmid (long tail, rat, amino acids 746–864) was
constructed into pGEX-4T-1 by subcloning the coding region
from GFP-tagged dynIaa (23). The sequence encoding the
dynIxb PRD (short tail, rat sequence, amino acids 746–851)
was amplified from dynIab in pCR3.1 expression vector (24)
with the oligonucleotides 5-CGGCGAATTCAACACGAC-
CACCGTCAGCACGCCC-3 and 5-CTGCAGAATTGCG-
GCCGCTTAGGGGTCACTGATAGTG-3 and then sub-
cloned into a pGEX-4T-1 vector (GE Healthcare). Point
mutants in dynIxb PRD were generated using the QuikChange
site-directed mutagenesis kit (Stratagene). The plasmid
expressing GST-amphiphysin I SH3 domain (human, amino
acids 545–695)was as previously reported (23).GST--adaptin
appendage domain (amino acids 701–938 in pGEX2T expres-
sion vector) was previously described (32). GST constructs
were transformed into Escherichia coli JM109 by heat shock,
and expressed recombinant proteins bound to glutathione
(GSH)-Sepharose beads were prepared according to the man-
ufacturer’s instructions. Cloning and expression of His6-synda-
pin 1-FL was as described previously (33).
Pull-down Experiments andMass Spectrometry—Crude (P2)
synaptosomes were prepared from rat brains (25) and lysed in
ice-cold buffer containing 20 mM Tris (pH 7.4), 150 mM NaCl,
1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 20 g/ml leupep-
tin, 1 mM phenylmethylsulfonyl fluoride (PMSF), and EDTA-
free Complete-protease inhibitor tablets (Roche Applied Sci-
ence). The homogenate was centrifuged at 75,600  g for 30
min at 4 °C. The extract was precleared with GSH-Sepharose
beads for 1 h and then incubated with the GSH-Sepharose
beads coated with GST recombinant proteins at 4 °C for 1 h.
The beads were isolated and washed extensively with ice-cold
lysis buffer and eluted in 2 concentrated SDS sample buffer.
Bound proteins were separated by 7.5–15% gradient SDS-
PAGE and stained with colloidal Coomassie Blue. Protein
bandswere then excised fromgels and identified by LC-MS/MS
(QSTAR XL mass spectrometer, AB SCIEX) and searched
against protein databases as described (27). See supplemental
Table 1 for more details.
Synaptosomes and 32Pi Labeling—P2 synaptosomes were
prepared from adult rat brains and labeled with 0.75 mCi/ml
32Pi for 1 h at 37 °C in a low calciumKrebs-like buffer (118.5mM
NaCl, 4.7 mM KCl, 1.18 mM MgCl2, 0.1 mM K2HPO4, 20 mM
Hepes, 10 mM glucose, with 0.1 mM calcium, pH 7.4) and
washed (25). In some experiments, the synaptosomes were
depolarized by the addition of KCl to 41 mM for 10 s, were
immediately lysed in ice cold lysis buffer (25 mM Tris, pH 7.4,
containing 1% Triton X-100, 150 mMNaCl, 1 mM EGTA, 2 mM
EDTA, 50 mM NaF, 20 g/ml leupeptin, 1 mM PMSF, and
EDTA-free protease inhibitor mixture), and were centrifuged
at 20,442  g for 20 min at 4 °C. Pull-down experiments were
performed sequentially. First, the GST-amphiphysin I-SH3
domain on GSH-Sepharose beads was used to pull down dynI
and synaptojanin from the lysate. Then GST--adaptin ear
domain on GSH-Sepharose beads was used in a subsequent
pull-down from the same lysate to isolate AP180 and
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amphiphysin. The washed beads were heated in SDS-PAGE
sample buffer, and proteins were resolved on SDS gels and sub-
jected to autoradiography. Densitometry was performed on
storage phosphor screens scanned with a Typhoon TRIO
imager, and phosphorylation was quantified with ImageQuant
TL software (GE Healthcare).
Cell Culture and Electron Microscopy—Primary cultures of
cerebellar granule neurons were prepared from the cerebella of
7-day-old Sprague-Dawley rat pups as described previously
(34). Cultures were processed for electron microscopy as
described previously (3) with minor modifications. Cultures
were removed into incubation medium (170 mM NaCl, 3.5 mM
KCl, 0.4 mM KH2PO4, 20 mM TES, 5 mM NaHCO3, 5 mM glu-
cose, 1.2mMNa2SO4, 1.2mMMgCl2, 1.3mMCaCl2, pH7.4) and
after 10 min were incubated with short (xb) peptide (30 or 60
M) for a further 15 min. Cultures were then stimulated with
800 action potentials (delivered at 80 Hz, 1-ms pulse width) in
incubation medium supplemented with horseradish peroxi-
dase (HRP; 10 mg/ml) and peptide where indicated. This stim-
ulation protocol activates both CME and ADBE (8). Neurons
were then immediately fixed in a 2% solution of glutaraldehyde
in PBS for 30 min at 37 °C. After washing in 100 mM Tris, pH
7.4, cultures were exposed to 0.1% diaminobenzidine and 0.2%
H2O2 in 100 mM Tris, pH 7.4. Upon development of color, cul-
tureswerewashedwith 100mMTris and thenpostfixedwith 1%
osmium tetroxide for 30 min. After washing, cultures were
poststained with 2% uranyl acetate for 15 min and then dehy-
drated using an ethanol series and polypropylene oxide and
then embedded using Durcupan. Samples were sectioned,
mounted on grids, and viewed using an FEI (Hillsboro, OR)
Tecnai 12 transmission electron microscope. Intracellular
structures that were100 nm in diameter were arbitrarily des-
ignated to be SVs, whereas larger structures were designated to
be endosomes. All experiments were performed on cultures
between 8 and 10 days in vitro. For transfection of CaNA or
CaNB into mammalian cells, COS-7 cells were grown in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum, and the transfection reagent was
FuGENE 6 (Roche Applied Science).
Fluorescence Imaging of Dextran Uptake—The uptake of
tetramethylrhodamine-dextran (40 kDa, 50M)wasmonitored
as described previously (3) in cells stimulatedwith a train of 800
action potentials (80 Hz, 10 s). Where indicated, cultures were
incubated with 60 M xb peptide for 15 min before and during
stimulation. Dextran loading was determined by the number of
fluorescent puncta in a defined field of view (130  130 m)
using a 20 air objective at 550-nm excitation and 575-nm
emission. Thresholding analysis was performed to discount
regions too large to represent individual nerve terminals
(diameter greater than 2 m). The average number of dextran
puncta/field for each experiment (usually 10 fields of view/ex-
periment) were averaged for the same conditions. Experiments
were performed acrossmultiple culture preparations; however,
to ensure that the density of nerve terminals was consistent
between fields and experimental conditions, for each set of cul-
tures, every experimental condition was performed (between
8–10 days in vitro).
RESULTS
Calcineurin Selectively Binds the Short DynIxb Splice Variant—
DynIxa and dynIxb differ in the amino acid sequences of their
alternatively spliced tails (Fig. 1A) (24, 25). To search for poten-
FIGURE 1. CaN specifically associates with short tailed dynIxb in a Ca2-
regulated manner. A, amino acid sequence alignment of the C terminus of
dynIxa (long) and dynIxb (short) splice variants. The amino acids in boldface
type are the alternatively spliced sequences. B and C, CaN specifically binds to
dynIxb PRD. Synaptosomal lysates were incubatedwith GST-dynI PRD (either
xa or xb) coupled to GSH-Sepharose beads. Bound proteins were separated
bySDS-PAGEand stainedwithCoomassie Blue. Theproteinsbound todynIxb
PRD at about 58 kDa (B) and about 19 kDa (C) were identified by LC-MSMS as
the A and B subunits of protein phosphatase 2B (calcineurin, CaNA, and
CaNB). D, bound proteins from pull-down experiments with dynI PRD (xa or
xb) were subjected to Western blot analysis with antibodies against CaNA,
CaNB, and amphiphysin I. E, binding of CaNA and CaNB subunits to GST-
dynIxb PRD is increased in the presence of Ca2, and CaM binds to dynIxb
PRD only in the presence of Ca2. Proteins from synaptosomal lysate were
pulled downbyGST-dynI PRD (xa or xb) in the absence or presence of 200M
Ca2. CaNorCaMbindingwas revealedbyWesternblot.F, CaNBbindsdynIxb
PRD via CaNA. COS7 cells were transiently transfected with either CaNA or
CaNB or cotransfected with both. Cell lysates were incubated with GST-dy-
nIxb PRD coupled to GSH-Sepharose beads. Bound proteins were subjected
toWestern blot analysiswith antibodies against CaNA andCaNB. Left, protein
expression in cell lysates; right, proteins bound to dynIxb PRD. G, synapto-
somal lysates were used for pull-down experiments with GST-dynIxb PRD in
the presence of EGTA (first data point) or various concentrations of Ca2.
Bound proteins were subjected to Western blot with antibodies against
CaNA, and the amount of proteins bound was quantified by densitometric
analysis of the blots. Data are normalized to 100% against maximumbinding
in 200 M Ca2. All gels and blots are representative of at least three (B–E) or
two (G) independent experiments, with some data for gels and blots being
shown in duplicate (B–E). Error bars, S.E.
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tial isoform-selective binding partners for the two tails, both
PRDs were expressed as GST fusion proteins bound to GSH-
Sepharose beads and incubated with rat brain synaptosomal
lysate for pull-down experiments. Proteins at about 58 and 19
kDa selectively associated with one form, dynIxb PRD (Fig. 1, B
and C). The 58-kDa protein was unequivocally identified by
LC-MS/MS sequencing as the catalytic subunit of the serine/
threonine-protein phosphatase 2B (CaN), also known asCaNA,
and the 19-kDa protein was identified as the regulatory subunit
of calcineurin, CaNB. The 58-kDa protein had 19 matching
peptides with 38% sequence coverage of CaNA  isoform 1 and
10 matching peptides with 36% sequence coverage of CaNA 
isoform 2 (supplemental Table 1). It also had eight matching
peptides with 20% sequence coverage of CaNA isoform, three
peptides being unique to the  not  isoform (supplemental
Table 1). Therefore, both CaNA  and  forms were unequiv-
ocally detected. The 19-kDa protein revealed seven matching
peptides with 53% sequence coverage of CaNB, matching both
known isoforms 1 and 2 (supplemental Table 2). The identity of
these proteins as CaNA and CaNB was independently con-
firmed by Western blotting with specific antibodies (Fig. 1D).
The blot was stripped and reprobed with anti-amphiphysin I
antibodies, and amphiphysin I was found to bind to xa and xb to
about the same extent (Fig. 1D). The results show that both
CaNA and CaNB specifically interact with the short dynIxb
splice variant but do not yet reveal which is the primary contact.
We next explored the potential Ca2 dependence of this
interaction. In the presence of 200 M Ca2, both CaNA and
CaNB increased binding to the dynIxb PRD (Fig. 1E and sup-
plemental Fig. S1,A and B). Interestingly, an additional band at
21 kDa was also detected in the Coomassie-stained gel, binding
specifically to dynIxbPRD (supplemental Fig. S1B). LC-MS/MS
clearly identified six tryptic peptides with 50% sequence cover-
age of calmodulin (CaM) (supplemental Table 3). This was con-
firmed by immunoblot analysis with specific anti-CaM anti-
bodies, which also revealed that CaMbound to the dynIxb-CaN
complex only in the presence of Ca2 (Fig. 1E, bottom). Because
CaNA and CaNB are known to be a complex, we asked which is
the primary contact with dynIxb. We transfected CaNA or
CaNB, or we cotransfected both, into COS7 cells. The cell
lysates were incubated with GST-dynIxb PRD onGSH-Sephar-
ose beads.Western blots showed that CaNAdirectly associated
with dynIxb PRD (Fig. 1F, top), whereas CaNB did not bind
alone, but bound dynIxb through CaNA (Fig. 1F, bottom). The
amount of CaNA bound to the dynIxb PRD in the presence of
various concentrations of Ca2 was further explored by West-
ern blot, and the level of bound CaNA was quantified by densi-
tometry. Maximal binding of CaNA to dynIxb PRD occurred at
about 1 M free Ca2, with an estimated EC50 for Ca2 of 0.1
M (Fig. 1G). This result is consistent with the previously
reported binding of dynI to CaN for calcium (EC50 in the range
of 0.1–0.4 M (21)). This affinity was similar to the in vitro
affinity of CaN for calcium (Kd value is less than 1M (35)). The
results show that it is the catalytic subunit that interacts with
dynIxb and that it has a high degree of constitutive binding.
Mapping the CaNA Binding Region in the DynIxb Short Tail—
To characterize dynIxb-CaNA binding, we used dynII PRD to
pull down proteins from synaptosomal lysates. Note that there
is only one known C-terminal tail for dynII, and its amino acid
sequence is more similar to that of dynIxa. No CaNA was
detected by immunoblot on dynII PRD (Fig. 2A). We also used
GST-CaNA(2–347)-coated GSH-Sepharose beads to pull
down its binding partners from synaptosomal lysate. The main
Coomassie protein band found to bind GST-CaNA(2–347)
comigrated on gels with the short form of dynI (dynIxb) (Fig.
2B, note the lower band of the doublet), whereas in contrast,
FIGURE 2. Mapping the CaN binding site within the dynIxb PRD. A, CaN
specifically binds to dynIxb PRD but not dynIIxa. Synaptosomal lysates were
incubated with GST-dynI PRD (either xa or xb) or GST-dynII PRD coupled to
GSH-Sepharose beads, and CaNA binding was revealed by Western blot. B,
dynIxb specifically binds to GST-CaNA. Synaptosomal lysates were incubated
with either GST-CaNA(2–347) or GST-AmpII-SH3 coupled to GSH-Sepharose
beads. Bound proteins were stainedwith Coomassie Blue after separation by
an acrylamide gel with low bis-acrylamide and elevated pH, which is known
to resolve the dynI splice variants (27). C, CaN binds to the alternatively
spliced C-terminal tail of dynIxb(844–851). Single point mutations were
made in the PRITIS motif of dynIxb PRD. The bacterially expressed mutant
GST-dynIxb PRDs were used for pull-down experiments from synaptosomal
lysates. Bound proteins were subjected to Western blotting with anti-CaNA
antibodies. D, mutations in the PRITIS motif do not affect amphiphysin I or
syndapin binding to dynIxb PRD. E, peptide competition revealed binding of
CaN to theC terminusof dynIxbPRD. Thepenetratin-taggedpeptidemimetic
of the short variant, dynIxb(842–851), containing theentire spliced insertwas
synthesized and used for competition studies. Synaptosomal lysates were
incubatedwithGST-dynIxb PRD immobilized onGSH-Sepharose beads in the
absence or presence of 5–100 M peptide. Binding of proteins was detected
by Western blot analysis with antibodies against CaNA, CaNB, syndapin, and
amphiphysin I. F, mutant peptide competition determined the specificity of
the binding of CaN to the C terminus of dynIxb PRD. The penetratin-tagged
mutant peptide containingARATAwas synthesized andused for competition
studies. Synaptosomal lysateswere incubatedwith GST-dynIxb PRD immobi-
lized on GSH-Sepharose beads in the absence or presence of 5–100 M
mutant peptide. Binding of proteins was detected by Western blot analysis
with antibodies against CaNA, syndapin, and amphiphysin I. G, CaN binding
to GST-dynIxb PRD is unaffected by the alternatively spliced C-terminal tail of
dynIxa(842–864). The penetratin-tagged peptide dynIxa(842–864) was syn-
thesized and used for a pull-down experiment as in E. CaNA binding to the
dynIxb PRD was analyzed by Western blot with anti-CaNA antibodies. All
results are representative of two independent experiments. AmphI and
AmphII, amphiphysin I and II, respectively.
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GST-AmpI-SH3 is known to associatewith dynI splice variants,
including dynIxa, dynIxb, and dynIxd (27). Mass spectrometry
analysis of the main band confirmed that CaNA binds dynIxb
with considerable specificity (data not shown). Due to the sen-
sitivity provided bymass spectrometry analysis, both dynIxa (in
the upper band) and dynIxd (in both upper and lower bands)
were detected, but not dynIxc. Considerably less Coomassie
protein stain was detected for dynIxa (Fig. 2B, lanes 1 and 2
versus lanes 3 and 4, upper band), despite the fact that dynamin
family members are well known to dimerize with each other
(36). It was not possible to quantify changes in dynIxd binding,
but like dynIxa, it has no specific sequencemotif to indicate that
it might interact with CaNA directly rather than indirectly via
dynIxb. These results suggest that CaNA specifically interacts
with the 7-amino acid tail that is unique to dynIxb.
Our next aim was to identify the binding site for CaN in the
short dynIxb variant. Inspection of the dynIxb tail sequence
(PRITISDP) revealed a strong similarity to the conserved CaN
docking motif PXIXI(T/S) (37, 38). To evaluate whether the
“PRITIS” region of dynIxb might be responsible for the CaN
interaction,we performed single pointmutations on each of the
three amino acids conserved in the motif. GST-dynIxb PRD
mutated at any of the three sites (P844A, I846A, or I848A) failed
to bind anyCaN in pull-downs fromnerve terminal lysates (Fig.
2, C and D). Binding to amphiphysin I and syndapin were not
affected by these mutations (Fig. 2D). To confirm that CaN
specifically binds to the short dynIxb tail, a synthetic PRITIS
peptide containing dynIxb(842–851) (GVPRITISDP)was fused
with a short penetratin heptapeptide RRMKWKK (“short pep-
tide”) and incubated with nerve terminal lysates prior to pull-
downs with GST-dynIxb PRD. The peptide reduced binding of
CaNA, CaNB, and CaM to the dynIxb PRD in a concentration-
dependent manner, both in the absence (Fig. 2E) and presence
of Ca2 (supplemental Fig. S2A), whereas the peptide did not
affect syndapin and amphiphysin I binding to dynIxb PRD (Fig.
2E). In contrast, a mutant PRITIS peptide, ARATASDP, fused
with RRMKWKK, did not disrupt any of the CaNA-dynIxb,
syndapin-dynI, and amphiphysin I-dynI interactions (Fig. 2F).
Another peptide containing the long dynIxa tail, dynIxa(842–
864) (RRMKWKK-GVPSRSGQASPSRPESPRPPFDL) (long
peptide), also did not disrupt the CaN-dynI interaction (Fig.
2G). Thus, we conclude that the PRITIS motif in the dynIxb
C-terminal splice site is the docking site forCaN, via the parallel
use of both mutagenesis and competitive peptides.
To determine whether CaN binding might be regulated by
dynI phosphorylation, we performed pull-down experiments
with GST-dynIxb PRD containing single or double point muta-
tions that introduce pseudophosphorylation at Ser-774 and/or
Ser-778, which are phosphosites known to regulate the interac-
tion of dynI with syndapin I (23). These were without effect on
CaNAbinding (supplemental Fig. S2B). The results suggest that
dynamin phosphorylation in the phospho-box region does not
regulate CaN binding to dynIxb. To determine whether other
protein-protein interactions might regulate CaN binding, we
prebound the GST-dynIxb PRD with His-tagged full-length
syndapin (which is itsmain binding partner forADBE) and then
performed the pull-down in synaptosomal lysates with this
complex. Prebinding of syndapin abolished the subsequent
CaNA-dynI interaction (supplemental Fig. S2C).
CaN Dephosphorylation of both DynIxa and DynIxb Splice
Variants Requires CaN Binding to the Short Form—CaN
dephosphorylates both dynIxa and dynIxb to an approximately
equal extent during nerve terminal depolarization (28). To
determine whether dynI dephosphorylation by CaN requires
CaN binding to dynIxb, we utilized 32Pi-labeled synaptosomes
that were depolarized with KCl either in the absence or pres-
ence of the dynIxb peptide or the CaN inhibitor cyclosporin A.
The dynIxb peptide and its inactive mutant control peptide
were tagged with a penetratin heptapeptide to facilitate entry
into synaptosomes (3, 39). Labeled synaptosomal lysates were
subjected to a pull-down with GST-amphiphysin I-SH3
domains on GSH beads, which extracted dynI and synaptoja-
nin. The lysates were then subjected to a second sequential
pull-down with GST--adaptin ear domain to further isolate
two other dephosphins, AP180 and amphiphysin I. Autora-
diography revealed that cyclosporin A prevented CaN-medi-
ated dephosphorylation of all four dephosphins in response to
the KCl depolarization (Fig. 3A and supplemental Fig. S3,A and
B; data shown in triplicate), but it did not affect the phosphor-
ylation of the four proteins under the control conditions (sup-
plemental Fig. S3,C andD). At a single concentration (100M),
the dynIxb peptide greatly reduced dynI dephosphorylation.
Surprisingly, it affected the upper and lower bands of the dynI
doublet to the same extent (Fig. 3A), despite the fact that CaN
docking could be demonstrated only to the shorter xb form.
When data from multiple independent experiments were
pooled and quantified, it was revealed that both dynIxa and -xb
dephosphorylationwere significantly blocked by the xb peptide
(Fig. 3, B andC). The effect was specific because the peptide did
not prevent the dephosphorylation of the three other dephos-
phins examined (Fig. 3, D–F, and supplemental Fig. S3, A and
B). In contrast, the inactive mutant peptide (100 M) did not
have any effects on any of the four proteins under any condi-
tions (Fig. 3, A–C, and supplemental Fig. S3, A–D). Therefore,
CaN binding to a single dynamin splice variant regulates KCl-
evoked dephosphorylation of two splice variants but not
dephosphorylation of at least three other dephosphins.
The CaN-DynIxb Interaction Regulates ADBE but Not CME—
The activity-dependent dephosphorylation of dynI by CaN and
the subsequent interaction with syndapin I is specifically
required for the ADBE mode of SV endocytosis, whereas dynI
GTPase activity is required for both ADBE and CME (2, 3, 23).
To determine whether the CaN-dynIxb interaction is re-
quired for either SV endocytosis mode, the dynIxb peptide
(dynIxb(842–851), GVPRITISDP) was introduced to primary
cultures of cerebellar granule neurons, in which expression of
dynIxa, -xb, and -xd was confirmed by pull-downs, Western
blots, and mass spectrometry (supplemental Fig. S4, A and B).
HRPwas used as a fluid phasemarker for parallel monitoring of
both ADBE and CME because it has been extensively charac-
terized in this neuronal system (3, 12, 40). ADBE is detected as
the very rapid appearance of large BE structures (100 nm in
diameter) filled with electron-dense reaction product in nerve
terminals, whereas CME is detected as electron-dense small
SVs (100nm indiameter). BothADBEandSVswere activated
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in the same nerve terminal after stimulation with a high inten-
sity train of 800 action potentials (80Hz), as revealed by amix of
small and large electron-dense vesicles (Fig. 4A). Both the
PRITIS and inactivemutant peptideswerewithout effect on the
number of HRP-labeled small diameter SVs at 60 M, but only
the PRITIS peptide reduced the number of large diameterHRP-
labeled endosomes (Fig. 4,B andC). Quantification of the num-
ber ofHRP-loaded SVs or BEs per nerve terminal frommultiple
independent experiments shows that the PRITIS peptide inhib-
its ADBE without a significant effect on CME (Fig. 4, D and E).
To independently confirm a block of ADBE, we used a com-
plementary assay based on uptake of the large (40-kDa) fluores-
cent tetramethylrhodamine-dextran. This dextran selectively
labels ADBE when applied during intense stimulation because
it is too large to enter single SVs. In agreement with the HRP
experiment, dextran uptake into nerve terminals does not
occur during mild neuronal activity when only CME is active
(8). The addition of the dynIxb peptide (60 M) significantly
reduced the uptake of dextran evoked by a train of 800 action
potentials (80 Hz) when compared with control conditions,
whereas the inactive mutant peptide did not have any effect
(Fig. 4, F–H). These results suggest that the interaction between
dynIxb and CaN is required for ADBE but not for CME.
DISCUSSION
We have shown that a single neuronal splice variant of the
classicalGTPase dynI, dynIxb, possesses a selective docking site
at its extreme C terminus for the catalytic subunit of the Ca2-
dependent protein phosphatase CaN. This docking site is
unique to dynIxb and conforms to the consensus PXIXI(T/S)
sequence observed in other CaN interaction domains. Inhibi-
tion of the CaN-dynIxb interaction resulted in a selective block
of dynI dephosphorylation over other CaN substrates and a
selective inhibition of ADBE over other SV endocytosis modes.
Our finding that CaN regulates dynI function through bind-
ing to the unique 7-amino acid sequence of the dynIxb variant
at PRITISDP, encompassing the entire spliced tail, provides a
surprising functional specificity for a single splice variant. This
amino acid sequence or motif is unique across all classical
dynamins and reported splice variants. We confirmed that
dynII did not bind CaN. Our study extends a previous report
that dynI binds the CaN complex (21) but reveals that the bind-
ing is specific to a single splice variant and is not a broader
dynamin property. We also find that the CaN-dynIxb interac-
tion occurs in the absence of Ca2, which differs from the pre-
vious study showing that the association was strictly Ca2-de-
pendent (21). We also observed a large increase in the binding
of the complex of CaNA andCaNB to dynIxb in the presence of
Ca2. However, CaNB interacted with dynIxb indirectly
through CaNA. CaNA associates with the CaNB subunit in the
presence or absence of Ca2 (35). Moreover, CaM also binds
CaNA in a Ca2-dependent manner (35). Analogously, the
transcription factor “nuclear factor of activatedT cells” (NFAT)
interacts more strongly with CaM-activated CaNA than inac-
tive CaNA (41), and CaN binding to TRESK is increased in the
presence of Ca2 and CaM (42). Our results suggest that an
active CaN complex is likely to be assembled on the tail of
dynIxb, allowing CaM and CaNB to synergistically activate
CaN phosphatase activity in the presence of increased intracel-
lular Ca2 (18, 43, 44). This suggests that Ca2 influx regulates
assembly of fully active CaN locally onto the tail of dynIxb in an
ordered manner.
FIGURE 3. The CaN-dynIxb interaction regulates KCl-evoked dynI
dephosphorylation but not that of three other dephosphins. A, synapto-
somes were metabolically labeled with 32Pi, washed, and incubated with or
without either 100 M PRITIS or 100 M ARATAS peptide or with 30 M
cyclosporinA for 15min. Synaptosomeswere then stimulatedwith 41mMKCl
for 10 s. After lysis, dynI and synaptojanin were isolated by pull-down with
GST-amphiphysin I-SH3 bound to GSH-Sepharose beads, and dynIxa and -xb
were separated by 12% acrylamide gel with 0.08% bisacrylamide and pH 9.2
(27). Proteins in the 100 kDa region containing the dynamins were visualized
by Coomassie Blue staining to demonstrate even sample loading (top). Phos-
phorylated dynIxa and -xb were visualized by autoradiography of triplicate
samples (bottom). Synaptojanin was visualized by a 7.5–15% gradient SDS-
PAGE (supplemental Fig. S3). Following this pull-down, two additional
dephosphins, AP180 and amphiphysin I, were extracted by a second sequen-
tial pull-down with GST--adaptin ear domain bound to GSH-Sepharose
beads of the same lysates (supplemental Fig. S3). B–F, quantitative analysis of
synaptosomal phosphorylation from several experiments, such as those
shown in A and supplemental Fig. 3, A and B for dynIxa (B), dynIxb (C), synap-
tojanin (D), amphiphysin I (E), andAP180 (F). Quantified data are presented as
a ratio of 32P levels (from phosphorimager data) normalized to the total pro-
tein from densitometry of the gel, and results were then normalized to levels
in the unstimulated controls. Results are themean S.E. forn 8 (from three
biologically independent experiments). One-way analysis of variance was
applied (***, p 0.001; **, p 0.01; *, p 0.05; all pairs were compared).
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Mammalian CaN does not bind to the vast majority of its
substrates. However, it does bind to a selective small group of
four,NFAT (45), the two-pore domainK channel TRESK (42),
AKAP79 (46), and neutral sphingomyelinase 2 (47). They share
in common a short consensus docking sequence motif,
PXIXI(T/S). This was first found in the sequence SPRIEIT in
the NFAT family of proteins (37, 38) and subsequently in the
others (42, 46–48). We found that GST-CaNA(2–347) pulled
down mainly the short form of dynI from rat synaptosomal
lysate despite the fact that it has been reported that different
dynI isoforms can assemble with each other to form either dim-
mers or tetramers (36). In that study,more than 30–40% of one
dynamin isoform could be co-immunoprecipitated by the anti-
bodies against another isoform (36). However, our results show
a surprisingly specific interaction of dynIxb with CaNA, and
this raises the possibility that in nerve terminals, the short form
might not necessarily occur as a multimer with the long form.
This raises the possibility that there might be different pools of
dynamin in neurons, some of whichmay contain just one single
isoform, and is consistent with markedly different stoichiome-
try of phosphorylation of dynIxa and -xb in verve terminals
(29).
We defined the CaN binding site in dynIxb by site-directed
mutagenesis and peptide competition as being PRITIS, a
sequence that conforms to the original CaN docking se-
quence SPRIEIT in NFAT. Docking of CaN to a select group of
its substrates appears to be a conservedmodel to provide strong
specificity to CaN signaling, despite the apparent availability of
a much larger substrate selection. For example, the transcrip-
tional activity of NFAT is dependent on its dephosphorylation
FIGURE 4. The CaN-dynIxb interaction is essential for ADBE. Cerebellar granule neuron cultures were incubated with 10 mg/ml HRP, and loading was
stimulated by a train of 800 action potentials delivered at 80 Hz. The cultures were incubated with either wild-type (xb) or mutant containing ARATA (xb mut)
penetratin-taggedpeptide dynIxb(842–851) (60M) for 15minbefore andduring stimulation.A–C, HRP-labeled structures in typical fields of vieweither in the
absence of peptide (A, Ctrl) or in the presence of mutant (B) or wild-type peptide (C). Scale bar, 150 nm in all images. D, mean number of HRP-labeled SVs
generated per nerve terminal in the presence of the peptide. E, mean number of HRP-labeled endosomes generated per nerve terminal in the presence the
peptide. Data were pooled from either four (Ctrl) or three (xbmut and xb) independent experiments (Ctrl, n 173 nerve terminals; xbmut, n 119; xb, n 87;
all mean S.E.; ***, p 0.001 compared with control, one-way analysis of variance; ns, not significantly different). F and G, dextran loading in typical fields of
view in cerebellar granule neurons either in the absence of xb peptide (F) or in its presence (G). Scale bars (F andG), 15m.H, granule neuronswere incubated
with 50 M tetramethyrhodamine-dextran and loading was stimulated by a train of 800 action potentials (80 Hz) followed by immediate dextran washout.
Where indicated, cultures were incubated with 60M either wild-type or mutant xb peptide 15min before and during stimulation. The data shown aremean
number of dextran puncta per field of view as a percentage of control (n 4 S.E.; **, p 0.01, one-way analysis of variance).
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by CaN (49–51). Disruption of the CaN-NFAT1 interaction
with a SPRIEIT peptide inhibited NFAT dephosphorylation
both in vitro and in vivo and also inhibited its nuclear translo-
cation and gene expression in T-cells, without inhibiting the
ability of CaN to dephosphorylate other endogenous proteins
(37). Similarly, we discovered that the peptide containing the
dynIxb(842–851) PXIXIS motif prevented CaN interaction
with dynIxb in vitro and selectively inhibited KCl-evoked dynI
dephosphorylation in nerve terminals but not that of three
other well characterized dephosphins, amphiphysin I, AP180,
and synaptojanin. This demonstrates that the peptide did not
block CaN activity but only its recruitment to dynIxb. Thus, the
specific anchoring of CaN to dynIxb may be employed in the
nerve terminal for ADBE in a similar manner to that seen with
NFAT1 in the cell body for transcriptional regulation.
CaN dephosphorylates dynI only during periods of high
activity. This event triggers an interaction with syndapin I for
ADBE (3, 52). Our finding that the dynI tail PRITIS peptide
dynIxb(842–851) selectively inhibits both ADBE and dynI
phosphorylation adds considerable support to the model in
which the action of CaN inADBE is primarilymediated by dynI
dephosphorylation. It may initially appear contradictory that
dynI is selectively involved with only one mode of SV endocy-
tosis when the use of the dynamin GTPase inhibitor dynasore
has shown that dynI is essential for all modes (2, 3). However,
there is a large pool of non-phosphorylated dynI in nerve ter-
minals representing 80%of the total (27) that is not regulated by
the signaling cascades that regulateADBE (6, 13). Therefore,we
propose that multiple pools of dynI reside in nerve terminals
and that CaN binding and phosphorylation mechanistically
separate a phospho-pool for ADBE, whereas the bulk of resid-
ual dynI is potentially available forCMEor other functions. The
ADBE-triggering action could therefore occur in two steps:
first, the Ca2-dependent recruitment of CaN to dynIxb (this
study) and, second, the dephosphorylation of dynI, thereby
triggering its binding to syndapin I (3, 13).Our results show that
prior binding of syndapin to dynIxb prevents CaN recruitment.
Because phosphorylation of dynI regulates its interaction with
syndapin but not CaN, we hypothesize that the wild type dynI
dissociates from CaN to associate with syndapin to play a key
role in ADBE. Interestingly, both splice variants are dephos-
phorylated by CaN, suggesting that ADBE might utilize either
variant.
Our results provide further evidence that CaN is required for
ADBE via its interaction with dynIxb and dephosphorylation of
dynI. In agreement, previous studies in chromaffin cells dem-
onstrate a CaN-sensitive form of endocytosis that was only
observed during high activity (53, 54). However, there are mul-
tiple CaN substrates in nerve terminals (e.g. the dephosphins)
that are dephosphorylated independently of the CaN-dynIxb
interaction and are linked to other SV endocytosis or trafficking
modes (17, 55). This suggests that CaN activity may play other
yet unidentified roles in the SV life cycle. Recent studies have
raised the possibility of new functions for CaN in SV turnover,
both during SV retrieval and during SV trafficking between
intracellular pools (56, 57). It will be interesting to determine
whether the targeted dephosphorylation of specific dephos-
phins may be responsible for these potential additional func-
tions. How such targeting occurs remains to be determined, but
possibilities include differential dephosphorylation by specific
trains of neuronal activity, anchoring in different nerve termi-
nal subdomains, or differential associationwithCaN-inhibitory
proteins (58).
In summary, we found that a short alternatively spliced insert
in dynI confers the ability of a single splice variant to bind to an
additional distinct partner, in addition to shared commonbind-
ing partners like syndapin, endophilin, and amphiphysin. The
CaN-dynIxb interaction, like the dynI-syndapin I interaction, is
required for ADBE but not for CME in neurons. Our results
suggest that CaN is specifically recruited to sites of ADBE by a
selective docking to the tail of a single dynI splice variant. To the
best of our knowledge, this is the first report of a selective cel-
lular function for one of the dynI splice variants. Our results
support a model whereby dynI dephosphorylation by CaN is
the primary trigger for ADBE during intense neuronal stimula-
tion, leading to the formation of a dynI-syndapin I complex as
the next step in the process of bulk endocytosis.
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